Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 10q Due Tuesday 1/17 - Why not file early?!

Get the report out of the way so that insiders can buy shares. Considering based on PTSC's business activity, the report is essentially a fill in the blanks with the new numbers kind of deal, it's difficult to understand why they couldn't file earlier than the deadline.

If they did, it would reflect positively on them and the comapny, IMO. Most importantly, it would allow them to begin buying shares as soon as the 10q is public!

Share
New Message
Please login to post a reply